GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NextCell Pharma AB (OSTO:NXTCL) » Definitions » Dividend Yield %

NextCell Pharma AB (OSTO:NXTCL) Dividend Yield % : 0.00% (As of Dec. 14, 2024)


View and export this data going back to 2017. Start your Free Trial

What is NextCell Pharma AB Dividend Yield %?

As of today (2024-12-14), the Trailing Annual Dividend Yield of NextCell Pharma AB is 0.00%.

The historical rank and industry rank for NextCell Pharma AB's Dividend Yield % or its related term are showing as below:

OSTO:NXTCL's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.39
* Ranked among companies with meaningful Dividend Yield % only.

NextCell Pharma AB's Dividend Payout Ratio for the three months ended in Aug. 2024 was 0.00.

As of today (2024-12-14), the Forward Dividend Yield % of NextCell Pharma AB is 0.00%.

NextCell Pharma AB's Dividends per Share for the three months ended in Aug. 2024 was kr0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


NextCell Pharma AB Dividend Yield % Historical Data

The historical data trend for NextCell Pharma AB's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextCell Pharma AB Dividend Yield % Chart

NextCell Pharma AB Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

NextCell Pharma AB Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of NextCell Pharma AB's Dividend Yield %

For the Biotechnology subindustry, NextCell Pharma AB's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NextCell Pharma AB's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NextCell Pharma AB's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where NextCell Pharma AB's Dividend Yield % falls into.



NextCell Pharma AB Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


NextCell Pharma AB  (OSTO:NXTCL) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


NextCell Pharma AB Dividend Yield % Related Terms

Thank you for viewing the detailed overview of NextCell Pharma AB's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


NextCell Pharma AB Business Description

Traded in Other Exchanges
Address
Karolinska Institutet Science Park, Halsovagen 7, Huddinge, SWE, 14157
NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.

NextCell Pharma AB Headlines

No Headlines